Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to epilepsy
- 167 Downloads
Methylenetetrahydrofolate reductase (MTHFR) gene C677T polymorphism was reported as risk factor for multiple diseases due to its role in conversion of homocysteine to methionine. The aim of the present meta-analysis was to find out the validity of association of C677T polymorphism with epilepsy susceptibility.
Pubmed, Science Direct, Springer Link and Google Scholar, databases were searched for relevant studies up to January, 31, 2018. The pooled odds ratios (ORs) with 95% confidence intervals (CIs) were performed using five genetic models. All statistical analysis was done by MetaAnalyst and Mix programs.
Except recessive model, significant association was found between MTHFR C677T polymorphism and epilepsy risk in other four genetic models (T vs C: OR = 1.29, 95% CI = 1.08–1.52, p = 0.004; TT vs CC: OR = 1.48, 95% CI = 1.19–1.82, p = 0.0003; TT + CT vs CC: OR = 1.20, 95% CI = 1.05–1.38, p = 0.008; TT vs CT + CC: OR = 1.35, 95% CI = 1.11–1.62, p = 0.002). Similarly, in the subgroup analysis based on ethnicity, significant association was found in Asian (T vs C: OR = 1.85; 95% CI = 1.15–2.99; p = 0.03) and Caucasian populations (TT vs CC: OR = 1.38; 95% CI = 1.10–1.1.73; p = 0.005). No evidence of heterogeneity and publication bias was detected in present meta-analysis.
In conclusion, results of present meta-analysis suggested that 677T allele of MTHFR is significantly increases the epilepsy susceptibility.
KeywordsEpilepsy Polymorphism MTHFR C677T Homocysteine Meta-analysis
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 4.Balamuralikrishnan B, Balachandar V, Mohana Devi S, Karthic Kumar A, Mustaq Ahammed SAK, Sasikala K (2013) Cytogenetic evaluation in epilepsy patients correlated with MTHFR C677T gene mutation and frequency of homocysteine levels. WCN 333:e44–e45. https://doi.org/10.1016/j.jns.2013.07.161 CrossRefGoogle Scholar
- 33.Kumar P, Yadav U, Rai V (2016) Methylenetetrahydrofolate reductase gene C677T polymorphism and breast cancer risk: evidence for genetic susceptibility. Meta Gene 6:2–84Google Scholar
- 41.Pepe G, Camacho Vanegas O, Giusti B, Brunelli T, Marcucci R, Attanasio M, Rickards O, de Stefano GF, Prisco D, Gensini GF, Abbate R (1998) Heterogeneity in world distribution of the thermolabile C677T mutation in 5,10-methylenetetrahydrofolate reductase. Am J Hum Genet 63:917–920CrossRefPubMedPubMedCentralGoogle Scholar
- 42.Rai V (2011a) Polymorphism in folate metabolic pathway gene as maternal risk factor for down syndrome. Int J Biol Med Res 2(4):1055–1060Google Scholar
- 43.Rai V (2011b) Evaluation of methylenetetrahydrofolate reductase gene variant (C677T) as risk factor for bipolar disorder. Cell Mol Biol 57:1558–1566Google Scholar
- 55.Rubino E, Ferrero M, Rainero I, Binello E, Vaula G, Pinessi L (2007) Association of the C677T polymorphism in the MTHFR gene with migraine: a meta-analysis. Cephalalgia 29:807–808Google Scholar
- 59.Sniezawska A, Dorszewska J, Rozycka A, Przedpelska-Ober E, Lianeri M, Jagodzinski PP, Kozubski W (2011) MTHFR, MTR, and MTHFD1 gene polymorphisms compared to homocysteine and asymmetric dimethylarginine concentrations and their metabolites in epileptic patients treated with antiepileptic drugs. Seizure 20:533–540CrossRefPubMedGoogle Scholar
- 61.Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283(15):2008–2012CrossRefPubMedGoogle Scholar
- 63.Thurman DJ, Beghi E, Begley CE, Berg AT, Buchhalter JR, Ding D, Hesdorffer DC, Hauser WA, Kazis L, Kobau R, Kroner B, Labiner D, Liow K, Logroscino G, Medina MT, Newton CR, Parko K, Paschal A, Preux PM, Sander JW, Selassie A, Theodore W, Tomson T, Wiebe S, for the ILAE Commission on Epidemiology (2011) Standards for epidemiologic studies and surveillance of epilepsy. Epilepsia 52:2–26CrossRefPubMedGoogle Scholar
- 65.Wallace BC, Dahabreh IJ, Trikalinos TA, Lau J, Trow P, Schmid CH (2013) Closing the gap between methodologists and end-users: R as a computational back-end. J Stat Software 49:1–15Google Scholar
- 66.World Health Organization (2001) International classification of functioning, disability and health. World Health Organization, GenevaGoogle Scholar